Health equity and health disparities have become familiar terms, particularly as the SARS-Cov2 pandemic exposed longstanding racial, ethnic, socio-economic, and geographic inequities in health. However, years of research have shown that even though we are more familiar with these terms, actively measuring, addressing, and dismantling unfair differences in health remains difficult. As a field that studies the effects of both diseases and their treatment in large groups of people, pharmacoepidemiology can play an important role in ensuring the health of real-world populations. The question is, how can pharmacoepidemiologists put health equity into practice? In this session, we will first define important concepts in Health Equity Research and consider these terms in the broader context research and healthcare. Next, we will discuss how to apply/adapt methods in pharmacoepidemiology research to measure health disparities. We will learn from the experiences of researchers in other fields of public health as well as from colleagues in pharmacoepidemiology in industry and academia. Attendees will leave the session with an understanding of what information and resources are needed to begin to put knowledge to practice.

• Identify examples of where concepts of health disparities and considerations of health equity are incorporated into ?public health research
• Identify priority health equity concepts to integrate into future pharmacoepidemiology research now
• Provide practical guidance on how to incorporate health equity in pharmacoepidemiology research